We are live on ! Find out more
OSUR icon

OraSure Technologies

152 hedge funds and large institutions have $479M invested in OraSure Technologies in 2014 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 44 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more call options, than puts

Call options by funds: $927K | Put options by funds: $255K

256% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 9

45% more capital invested

Capital invested by funds: $330M → $479M (+$149M)

23% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 44

16% more funds holding

Funds holding: 131152 (+21)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
152
Holders Change
+21
Holders Change %
+16.03%
% of All Funds
4.05%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
54
Reduced
44
Closed
9
Calls
$927K
Puts
$255K
Net Calls
+$672K
Net Calls Change
+$558K
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$5.59M +$795K +88,675 +19%
JGC
27
J. Goldman & Co
New York
$5.58M -$1.7M -190,000 -26%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$5.16M -$1.21M -134,947 -21%
Renaissance Technologies
29
Renaissance Technologies
New York
$4.83M -$535K -59,700 -11%
TCM
30
Tygh Capital Management
Oregon
$4.81M +$4.25M +474,610 New
Allianz Asset Management
31
Allianz Asset Management
Germany
$4.67M +$2.3M +257,185 +127%
QI
32
QS Investors
New York
$4.51M +$3.99M +444,980 New
TC
33
TFS Capital
Pennsylvania
$4.51M +$2.22M +247,782 +126%
Principal Financial Group
34
Principal Financial Group
Iowa
$4.23M -$184K -20,540 -5%
Morgan Stanley
35
Morgan Stanley
New York
$4.13M +$1.85M +206,917 +104%
FAM
36
Fred Alger Management
New York
$4.02M +$3.55M +396,595 New
Ameriprise
37
Ameriprise
Minnesota
$3.87M +$947K +105,705 +38%
ACM
38
Ashford Capital Management
Delaware
$3.71M
TCIM
39
TIAA CREF Investment Management
New York
$3.69M +$230K +25,630 +8%
Geode Capital Management
40
Geode Capital Management
Massachusetts
$3.58M +$311K +34,728 +11%
HP
41
Harvey Partners
New York
$3.55M +$896K +100,000 +40%
Norges Bank
42
Norges Bank
Norway
$3.49M +$3.08M +343,841 New
CCM
43
Cupps Capital Management
Illinois
$3.37M +$2.98M +332,330 New
Massachusetts Financial Services
44
Massachusetts Financial Services
Massachusetts
$3.15M +$53.5K +5,967 +2%
BIM
45
Bogle Investment Management
Massachusetts
$2.94M -$248K -27,680 -9%
JP Morgan Chase
46
JP Morgan Chase
New York
$2.68M +$1.31M +145,834 +123%
BBA
47
Baker Bros. Advisors
New York
$2.38M
EIM
48
Essex Investment Management
Massachusetts
$2.38M +$511K +57,072 +32%
RCAMU
49
Rothschild & Co Asset Management US
Connecticut
$2.33M -$2.47M -275,540 -54%
GIP
50
Granite Investment Partners
California
$2.29M +$1.37M +153,326 +212%

OSUR Hedge Fund Activity: Q4 2014 in Review

152 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in OraSure Technologies (OSUR) for Q4 2014, worth a combined $479M — up 45% from $330M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new OSUR positions and 9 closed out — a net gain of 23 holders — while 54 added to existing stakes and 44 trimmed.

The largest buyer was Guggenheim Capital, opening a new position worth an estimated $10M. The largest seller was OrbiMed, cutting an estimated $30.4M.

  • 152 institutional investors held OraSure Technologies (OSUR) as of Q4 2014, up from 131 in Q3 2014.
  • Funds reported $479M of OraSure Technologies stock for Q4 2014, up 45% quarter-over-quarter.
  • 32 funds opened new OraSure Technologies positions in Q4 2014 and 9 closed out, a net change of +23 holders.
  • The largest OraSure Technologies buyer in Q4 2014 was Guggenheim Capital, an estimated $10M added.
  • The largest OraSure Technologies seller in Q4 2014 was OrbiMed, an estimated $30.4M sold.

Based on aggregated 13F filings for Q4 2014.